WHO ICTRP trial
One-year Efficacy of Adjunctive Use of Ripasudil, a Rho-Kinase Inhibitor, in…
JPRN-UMIN000026228 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000026228 |
|---|---|
| Public title | One-year Efficacy of Adjunctive Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients with Glaucoma Inadequately Controlled under Maximum Medical Therapy |
| Scientific title | One-year Efficacy of Adjunctive Use of Ripasudil, a Rho-Kinase Inhibitor, in Patients with Glaucoma Inadequately Controlled under Maximum Medical Therapy - One-year efficacy of Ripasudil |
| Primary sponsor | Department of Ophthalmology and Micro-technology, Yokohama City University School of Medicine, Yokohama, Japan |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | Prymary open angle glaucoma |
| Registration date | Feb 20, 2017 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: